0.6288
0.63 (-0.36%)
As of Mar 07, 2023
Sesen Bio, Inc. [SESN]
Source:
Company Overview
Sesen Bio, Inc. is a late-stage clinical company that previously focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer.
| Country | United States |
| Headquarters | philadelphia, pennsylvania |
| Phone Number | 2674916422 |
| Industry | manufacturing |
| CEO | Thomas R. Cannell, D.V.M. |
| Website | www.sesenbio.com |